Bionano Genomics Inc (NASDAQ: BNGO) is -53.97% lower on its value in year-to-date trading and has touched a low of $0.95 and a high of $11.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNGO stock was last observed hovering at around $0.98 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $0.87, the stock is -16.11% and -22.48% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.16 million and changing -11.00% at the moment leaves the stock -64.41% off its SMA200. BNGO registered -92.50% loss for a year compared to 6-month loss of -64.20%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.71% gain in the last 1 month and extending the period to 3 months gives it a -36.03%, and is -17.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.09% over the week and 7.95% over the month.
Bionano Genomics Inc (BNGO) has around 344 employees, a market worth around $53.27M and $36.12M in sales. Profit margin for the company is -643.74%. Distance from 52-week low is -8.72% and -92.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-225.00%).
The EPS is expected to grow by 72.17% this year.
Bionano Genomics Inc (BNGO) Top Institutional Holders
The shares outstanding are 61.23M, and float is at 60.58M with Short Float at 8.70%.
Bionano Genomics Inc (BNGO) Insider Activity
The most recent transaction is an insider purchase by Mamuszka Hannah,the company’sDirector. SEC filings show that Mamuszka Hannah bought 65,789 shares of the company’s common stock on Jun 13 ’23 at a price of $0.76 per share for a total of $50000.0. Following the purchase, the insider now owns 65789.0 shares.
Bionano Genomics Inc disclosed in a document filed with the SEC on May 16 ’23 that Holmlin R. Erik (President and CEO) bought a total of 15,000 shares of the company’s common stock. The trade occurred on May 16 ’23 and was made at $0.64 per share for $9639.0. Following the transaction, the insider now directly holds 0.81 million shares of the BNGO stock.
Still, SEC filings show that on May 12 ’23, Stewart Christopher P. (Chief Financial Officer) acquired 50,000 shares at an average price of $0.67 for $33415.0. The insider now directly holds 281,373 shares of Bionano Genomics Inc (BNGO).
